Yes, based on your personal risk. The vaccine substantially decreases your risk of severe disease from SARS-CoV-2 infection, even if you think that is a low bas

Yes, based on your personal risk. The vaccine substantially decreases your risk of severe disease from SARS-CoV-2 infection, even if you think that is a low baseline risk. As a young person this comes with a slightly elevated risk of myocarditis, which can be mitigated by taking BNT (30 ug dose) or a half dose of moderna (50 dose). The UK study being discussed elsewhere in here estimates that risk (for young people) on par with risk of myocarditis from SARS-CoV-2 infection If you have had a confirmed infection in the past then you have some immunity so the calculus is a bit different. Probably you should still get one vaccine dose, especially if your infection was pre-omicron My main point is, there is plenty of data available for people to make this assessment for themselves, and holding out for FDA release is not going to provide meaningfully better insight into this risk assessment